Src Inhibitor 1

CAS No. 179248-59-0

Src Inhibitor 1( Src I1 | Src I-1 | SrcI1 )

Catalog No. M17379 CAS No. 179248-59-0

Src Inhibitor 1 is a potent and selective dual site Src tyrosine kinase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 40 In Stock
5MG 60 In Stock
10MG 83 In Stock
25MG 195 In Stock
50MG 353 In Stock
100MG 518 In Stock
500MG 1098 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Src Inhibitor 1
  • Note
    Research use only, not for human use.
  • Brief Description
    Src Inhibitor 1 is a potent and selective dual site Src tyrosine kinase inhibitor.
  • Description
    Src I1 is a potent, competitive dual site (ATP- and peptide-binding) Src kinase inhibitor (IC50 values are 44 and 88 nM for Src and Lck respectively).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Src I1 | Src I-1 | SrcI1
  • Pathway
    Immunology/Inflammation
  • Target
    Lipoxygenase
  • Recptor
    Lck| Src
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    179248-59-0
  • Formula Weight
    373.4
  • Molecular Formula
    C22H19N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 9.09 mg/mL. 24.34 mM;
  • SMILES
    COc1c(cc2c(c1)c(ncn2)Nc1ccc(cc1)Oc1ccccc1)OC
  • Chemical Name
    6,7-Dimethoxy-N-(4-phenoxyphenyl)-4-quinazolinamine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Tian G, et al. Structural determinants for potent, selective dual site inhibition of human pp60c-src by 4-anilinoquinazolines. Biochemistry. 2001 Jun 19;40(24):7084-91.
molnova catalog
related products
  • 11-Keto-beta-boswell...

    11-Keto-beta-boswellic acid, a novel Nrf2 activator, and a selective 5-lipoxygenase (5-LOX) inhibitor.

  • 3-Hydroxycoumarin

    3-Hydroxycoumarin is a natural compound and is?human 15-LOX-1 inhibitors.

  • PXS-6302 hydrochlori...

    PXS-6302 hydrochloride is a potent irreversible lysine oxidase (LOX) inhibitor, inhibiting Bovine LOX, rh LOXL1, rh LOXL2, rh LOXL3, and rh LOXL4 with IC50 of 3.7 μM, 3.4 μM, 0.4 μM, 1.5 μM, and 0.3 μM, respectively.